Trial
NCT01409811
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
City of Hope Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Estrogen Receptor-positive Breast Cancer
Intervention
zoledronic acid
Why stopped
Study closed after it became too difficult to interest patients in participating.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-08